Company intelligence / Profile preview

Resvent

Dongguan/Shenzhen, Guangdong, Chinaresvent.com ↗

Ownership: Private
Development stage: Other

Overview

Resvent develops and markets high-end respiratory medical equipment including CPAP/BiPAP devices for sleep apnea and ventilators for chronic and acute respiratory conditions. Their products are available internationally and are in the process of obtaining FDA 510(k) clearance in the United States. The company emphasizes AI-driven features to improve patient adherence and integrates digital healthcare solutions.

Therapeutic areas: Pulmonology
Modalities: Device
Industry: Therapeutic Medical Devices

Partnerships

Collaborations with hospitals for public health clinics focused on sleep health awareness

Beyond the preview

Go deeper on Resvent.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Resvent.

Explore the full profile